Overview

Assessing the Effects of FanaptĀ® on Social Cognition in Schizophrenia

Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The study looks at whether treatment with iloperidone (Fanapt) is associated with improvements in social cognition in individuals who have been recently diagnosed with schizophrenia or schizoaffective disorder. Social cognition (the ability to understand your feelings and the feelings of others) is closely related to functional outcomes, including communication, empathy, and emotional recognition.
Phase:
Phase 4
Details
Lead Sponsor:
Northwestern University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Iloperidone